blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1311704

EP1311704 - NOVEL TARGET GENES FOR DISEASES OF THE HEART [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.04.2004
Database last updated on 05.10.2024
Most recent event   Tooltip20.06.2008Change - representativepublished on 23.07.2008  [2008/30]
Applicant(s)For all designated states
MediGene AG
Lochhamer Strasse 11
82152 Planegg/Martinsried / DE
[N/P]
Former [2003/21]For all designated states
Medigene AG
Lochhamer Strasse 11
82152 Planegg/Martinsried / DE
Inventor(s)01 / BUNK, Daniela
Hofmark 8
82393 Iffeldorf / DE
02 / REUNER, Birgit
Heiterwangerstrasse 10
81373 Munich / DE
03 / BECK, Joachim
Herterichstrasse 115
81477 Munich / DE
04 / HENKEL, Thomas
Freienfelsstrasse 20a
81249 Munich / DE
05 / STOSS, Oliver
Brunellenweg 29
D-80689 München / DE
 [2003/21]
Representative(s)Leidescher, Thomas, et al
Zimmermann & Partner Patentanwälte mbB
Postfach 330 920
80069 München / DE
[N/P]
Former [2008/30]Leidescher, Thomas, et al
Zimmermann & Partner Postfach 330 920
80069 München / DE
Former [2003/21]Leidescher, Thomas, Dr., et al
Zimmermann & Partner, Postfach 33 09 20
80069 München / DE
Application number, filing date01940545.530.05.2001
[2003/21]
WO2001EP06165
Priority number, dateUS20000207400P30.05.2000         Original published format: US 207400 P
[2003/21]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0192567
Date:06.12.2001
Language:EN
[2001/49]
Type: A2 Application without search report 
No.:EP1311704
Date:21.05.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 06.12.2001 takes the place of the publication of the European patent application.
[2003/21]
Search report(s)International search report - published on:EP13.02.2003
ClassificationIPC:C12Q1/68, A01K67/027, A61K49/00, C07K16/18, G01N33/53
[2003/21]
CPC:
C12N15/8509 (EP,US); A61P9/00 (EP); A61P9/02 (EP);
A61P9/04 (EP); A61P9/10 (EP); A61P9/12 (EP);
C07K14/47 (EP,US); C12Q1/6883 (EP,US); A01K2217/05 (EP,US);
A01K2217/075 (EP,US); A01K2267/03 (EP,US); A01K2267/0375 (EP,US);
C12Q2600/136 (EP,US); C12Q2600/158 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/21]
TitleGerman:NEUARTIGE ZIELGENE FÜR HERZERKRANKUNGEN[2003/21]
English:NOVEL TARGET GENES FOR DISEASES OF THE HEART[2003/21]
French:NOUVEAU GENES CIBLES POUR LES MALADIES DU COEUR[2003/21]
Entry into regional phase22.10.2002National basic fee paid 
22.10.2002Designation fee(s) paid 
22.10.2002Examination fee paid 
Examination procedure14.12.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.10.2002Examination requested  [2003/21]
01.11.2003Application deemed to be withdrawn, date of legal effect  [2004/25]
13.01.2004Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2004/25]
Fees paidPenalty fee
Additional fee for renewal fee
31.05.200303   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO9101498  (VIOCLONE BIOLOG INC [CA]) [Y] 40,41,47 * the whole document *;
 [A]WO9813476  (LEINWAND LESLIE A [US], et al);
 [Y]DE19725186  (MEDIGENE AG [DE]) [Y] 1-41,47 * page 7, line 55 - page 8; claims 6-15 *;
 [A]WO9919471  (UNIV TEXAS [US], et al);
 [Y]WO9924571  (CURAGEN CORP [US], et al) [Y] 1-41,47 * the whole document *;
 [Y]WO9949062  (GENE LOGIC INC [US], et al) [Y] 1-41,47 * claims 17-22 *;
 [Y]WO9950410  (VICTOR CHANG CARDIAC RESEARCH [AU], et al) [Y] 1-41,47 * the whole document *;
 [X]  - WALKER M ET AL, "Cardiomyopathy-associated genes identified by genome-scale expression analysis", EMBL, EBI, (20000503), Database accession no. AW755252, XP002203686 [X] 1-41,47 * abstract *
 [X]  - AIHARA Y ET AL, "CARDIAC ANKYRIN REPEAT PROTEIN CARP IN A NOVEL MARKER OF MYOCARDIAL STRESS: REGULATION OF TRANSCRIPTION THROUGH M-CAT ELEMENT BY STRESS-RESPONSIVE MAP KINASE PATHWAYS", CIRCULATION, AMERICAN HEART ASSOCIATION, DALLAS, TX, US, (19991102), vol. 110, no. 18, SUPPL, ISSN 0009-7322, pages I - 627-I-628, XP001056080 [X] 1-41,47
 [Y]  - LOWES B D ET AL, "CHANGES IN GENE EXPRESSION IN THE INTACT HUMAN HEART. DOWNREGULATION OF ALPHA-MYOSIN HEAVY CHAIN IN HYPERTROPHIED, FAILING VENTRICULAR MYOCARDIUM", JOURNAL OF CLINICAL INVESTIGATION, NEW YORK, NY, US, (19971101), vol. 100, no. 9, ISSN 0021-9738, pages 2315 - 2321, XP002910970 [Y] 1-41,47 * the whole document *

DOI:   http://dx.doi.org/10.1172/JCI119770
 [Y]  - KELLER ET AL, "Differential expression of alpha- and beta-enolase genes during rat heart development and hypertrophy", AMERICAN JOURNAL OF PHYSIOLOGY: HEART AND CIRCULATORY PHYSIOLOGY, THE AMERICAN PHYSIOLOGICAL SOCIETY, XX, (19951201), vol. 38, no. 6, ISSN 0363-6135, pages H1843 - H1851, XP002096499 [Y] 1-41,47 * the whole document *
 [Y]  - BOHELER ET AL, "Gene expression in cardiac hypertrophy", TRENDS IN CARDIOVASCULAR, ELSEVIER SCIENCE, NEW YORK, NY, US, (19920901), vol. 2, no. 5, ISSN 1050-1738, pages 176 - 182, XP002096139 [Y] 1-41,47

DOI:   http://dx.doi.org/10.1016/1050-1738(92)90046-U
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.